Disfunção sexual em mulheres com câncer de mama

• Autor(a) principal: Lopes, Juliane da Silveira Ortiz de Camargo
• Data de Publicação: 2015
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Repositório Institucional da UFG
• Texto Completo: http://repositorio.bc.ufg.br/tede/handle/tede/4948
• topic: Câncer de mama; Sexualidade; Disfunção sexual; Ansiedade; Depressão; Breast cancer; Sexuality; Sexual dysfunction; Anxiety; Depression; CIENCIAS DA SAUDE::ENFERMAGEM

INTRODUCTION: Sexual dysfunctions are changes that often affect women with breast cancer as a result of multiple factors, particularly physical changes, treatment and course of the disease, but they can also be associated with cases of anxiety and depression. PURPOSE: Evaluate sexual dysfunction in women with breast cancer and associated factors. METHODS: Cross-sectional study with 167 women being treated for breast cancer at an oncology reference hospital in Goiânia-GO, from August to November 2014. Factors associated with sexual dysfunction in this group were assessed using a semi-structured script prepared by the researcher, the field of sexuality: desire, arousal, lubrication, orgasm, satisfaction and pain / discomfort were analyzed by applying the "Female Sexual Function Index (IFSF)" and anxiety and depression were checked using the Hospital Anxiety and Depression Scale (HADS ). The project was approved by the ethics committee of Hospital das Clinicas of research at the Federal University of Goiás and the Association Against Cancer in Goiás. Data analysis was performed using the chi-square test, Student's t test and Pearson's correlation considering the significance level of p <0.05. RESULTS: It was found that 79.0% of the sample had sexual dysfunction and of these, 86.8% and 86.3% had anxiety and depression, respectively. There was an association between various treatments for breast cancer as mastectomy, quadrantectomy, chemotherapy, chemo / radiotherapy (p <0.05) and the decline in scores in all areas of sexuality (desire, arousal, lubrication, orgasm, satisfaction and pain / discomfort) in women with sexual dysfunction. Other factors such as comorbidities (p = 0.042) and nonexistent menstrual cycle (p = 0.014) showed a significant association with sexual dysfunction in this group. There was a significant association between the presence of sexual dysfunction and anxiety in women with breast cancer (p = 0.038). Regarding the fields of sexuality it found that women with sexual dysfunction had a positive and significant correlation between anxiety and sexual arousal and a significant correlation, but inversely, between depression and sexual desire. CONCLUSION: Sexual dysfunction has affected 79% of women with breast cancer, causing decline in scores in all areas of sexuality. Factors such as comorbidity, non-existent menstrual cycle and anxiety were significantly associated with sexual dysfunction. Depression has an inverse correlation to the domain desire in this group.